Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09LSY
|
||||
| Former ID |
DIB014513
|
||||
| Drug Name |
EDP-322
|
||||
| Synonyms |
EP-16322; Antibacterial (oral, Gram-positive infections), Enanta; EDP-MRSA-1 (oral), Enanta
|
||||
| Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Phase 1 | [548796] | ||
| Company |
Enanta Pharmaceuticals Inc
|
||||
| Canonical SMILES |
c1(nc(cs1)N)c1ccc(nc1)CO/N=C/1\CO[C@H]2[C@](C)(O)[C@H](<br />OC(=O)[C@](F)(C)C(=O)[C@@H]([C@H]([C@](OC1)(C[C@H](/C(=<br/>N\C(=O)CC)/[C@@H]2C)C)C)O[C@H]1[C@@H]([C@H](C[C@H](O1)C<br />)N(C)C)O)C)CC
|
||||
| Target and Pathway | |||||
| Target(s) | Multidrug resistance protein 1 | Target Info | Inhibitor | [532939] | |
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.